KYTHERA (NASDAQ: KYTH) is a biopharmaceutical company that focuses on developing and commercializing high-demand medical aesthetics products. We target large-scale global opportunities to develop innovative drugs and medical devices to treat under-addressed aesthetic complaints. We look for market segments with both motivated patients and motivated physicians. Our longer-term strategy is to leverage our biotechnology and aesthetics experience to aggressively expand our product portfolio and pipeline.
May 19, 2015
May 8, 2015
KYTHERA Biopharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
May 14, 2015 at 10:40 AM PT
May 7, 2015 at 1:30 PM PT